Skip to main content

A raft of major banks and fund managers have upgraded their view on global equities, with emerging-market stocks their top pick to benefit from signs of easing in the Sino-U.S. trade dispute.

Fund manager J.P. Morgan Asset Management raised its outlook on global stocks, pointing to hopes for a breakthrough in the U.S.-China trade discussions, a reduced risk of a U.S. recession and a moderately positive earnings outlook.

The call, from the manager of US$1.8-trillion in assets, comes as U.S. stock markets sit at a record high but a recent bond rally shows signs of unwinding.

Story continues below advertisement

“We have held a cautious view on the outlook for equity markets for much of this year … however, the environment has shifted in recent weeks” Patrik Schowitz, global multi-asset strategist at the fund manager, said in an e-mailed note.

“That change likely reflects several factors, which we think has some more room to run,” he said.

Mr. Schowitz cited renewed optimism that Beijing and Washington will reach an agreement to end their trade dispute, recession risk in the U.S. dropping from an even chance to 20 per cent to 30 per cent and the possibility of earnings growth as the main factors. He did not specify how the upgrade would affect asset allocation nor offer target levels for equity indices.

Emerging-market equities were the most favoured pick, alongside U.S. large-cap equities, Mr. Schowitz said.

Meanwhile, UBS said it was closing its underweight to emerging-market stocks and moved its overall position on equities to neutral.

“There have been material signs a U.S.-China deal is more likely, while monetary policy and economic fundamentals are also now more supportive,” said Mark Haefele, chief investment officer at UBS Global Wealth Management. “While equity prices have risen and downside risks remain, upside potential has also increased.”

Morgan Stanley also joined in, upgrading emerging-market equities to equal weight from underweight on a better global growth outlook outside the U.S., singling out South Korea which it upped to overweight.

Story continues below advertisement

Morgan Stanley saw the biggest potential in markets with a clearer path to earnings growth, such as developing-market stocks and Japan, or a scope for multiple rerating on falling political risks, such as Europe.

“Neither of these factors are at play in the U.S., where we remain UW [underweight] given peak earnings risk, higher relative valuation and unique political risk to sentiment,” it added.

Rabobank also spotted signs of change, saying November’s divergence between the MSCI emerging-markets stocks index and the S&P 500 Index against the MSCI Emerging Market Currency Index, which during September and October rose in tandem, was unlikely to last.

“Either EM stocks will start to outperform U.S. equities and the ratio rises sharply or the MSCI EM FX Index falls,” it said.

World shares were close to a record high on Monday after Beijing surprised markets by trimming a key interest rate for the first time since 2015, stirring speculation that further stimulus was on the way for the world’s second-largest economy.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies